Predicting Tumor Mutational Burden (TMB) and Tumor Neoantigen Burden (TNB) of East Asian ANSCLC Patients by a Targeted Genomic Profiling

被引：0

作者：

Chen, L. ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

tumor mutational burden (TMB); tumor neoantigen burden (TNB); a Targeted Genomic Profiling (TGP; targeting; 811; genes);

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.07-026

引用

页码：S2005 / S2005

页数：1

共 50 条

[41] Validation of TMB (tumor mutational burden) quantification using putative driver mutations in customized targeted sequencing platform.
Kwon, Woo Sun
Che, Jingmin
Rha, Sun Young
Chung, Hyun Cheol
CANCER RESEARCH, 2022, 82 (12)
[42] Prognosis Determined by Tumor Mutational Burden (TMB) Using Whole Exome Sequencing (WES)
Fernandez, E.
Eng, K.
Sboner, A.
Elemento, O.
Song, W.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1013 - 1013
[43] Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study
Duvivier, Herbert L.
Rothe, Michael
Mangat, Pam K.
Garrett-Mayer, Elizabeth
Ahn, Eugene R.
Al Baghdadi, Tareq
Alva, Ajjai S.
Dublis, Stephanie A.
Cannon, Timothy L.
Calfa, Carmen J.
Li, Rui
Behl, Deepti
Chiu, Vi K.
Gold, Philip J.
Marr, Alissa S.
Mileham, Kathryn F.
Powell, Steven Francis
Rodon, Jordi
Thota, Ramya
Grantham, Gina N.
Gregory, Abigail
Hinshaw, Dominique C.
Halabi, Susan
Schilsky, Richard L.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5140 - +
[44] Pan-Cancer assessment of tumor mutational burden using a comprehensive genomic profiling assay.
Nichol, Donna
Jones, Sian
Angiouli, Samuel V.
Keefer, Laurel
Nesselbush, Monica
Sengamalay, Naomi
White, James
Simmons, John
Diaz, Luis A.
Velculescu, Victor E.
Sausen, Mark
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
[45] ROUTINE USE OF COMPREHENSIVE GENOMIC PROFILING TO ASSESS TUMOR MUTATIONAL BURDEN ACROSS A COMMUNITY HEALTH SYSTEM
Bifulco, Carlo
Weerasinghe, Roshanthi
Bapat, Bela
Dowdell, Alexa
Pindikuri, Shwetha
Reynolds, Sheila
Biery, Nancy
Ball, David
Campbell, Mary
Ward, Thomas
Stein, Alisha
Schroeder, Brock
Eberhard, David
Piening, Brian
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A44 - A45
[46] The value of tumor mutational burden to select patients for immunotherapy
Wagener-Ryczek, Svenja
Buettner, Reinhard
EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (01) : 1 - 3
[47] Landscape of Tumor Mutational Burden in Indian NSCLC Patients
Mehta, P.
Dhabhar, B.
Bhatt, A.
Dattatreya, P.
Maru, A.
Vijayakumar, R.
Maniar, V.
Basade, M.
Patel, K.
Alurkar, S.
Bahl, C.
Todur, S.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S462 - S463
[48] The emerging development of tumor mutational burden in patients with NSCLC
Zhang, Yu
Wang, Lifeng
Li, Rutian
Liu, Baorui
FUTURE ONCOLOGY, 2020, 16 (09) : 469 - 481
[49] Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma
Chen, Xusheng
Ou, Zhenyu
Wang, Lei
Zhang, Zhenting
Fan, Xiaodong
Liu, Huanhuan
Wang, Wenping
Zhang, Yanrui
Zhu, Jun
Liang, Xiayuan
Lou, Feng
Cao, Shanbo
Yao, Ye
Wang, Huina
Yao, Xin
MOLECULAR CARCINOGENESIS, 2022, 61 (03) : 311 - 321
[50] Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy
Pinato, David J.
Urus, Heather
Newsom-Davis, Thomas
Du Parcq, Persephone
Belessiotis, Katherine
Mapara, Leah
Gupta, Nandita
Power, Danielle
Weir, Justin
Wong, Ching Ngar
Ratnakumaran, Ragu P.
Dominy, Kathy
Khorashad, Jamshid
Bower, Mark
JOURNAL OF IMMUNOTHERAPY, 2020, 43 (02) : 53 - 56

← 1 2 3 4 5 →